Researchers have shown that a new typhoid vaccine called Vi-TT is safe, well-tolerated and could be effective in tackling typhoid rates in affected areas.
The G20 summit starts today in Hamburg. Jeremy Farrar, Wellcome's Director, and Paul Stoffels, Chief Scientific Officer of Johnson & Johnson, urge them to keep up the momentum in tackling infectious disease outbreaks.
In an open letter, our Director Jeremy Farrar congratulates the new head of the World Health Organization Tedros Adhanom Ghebreyesus, and sets out what Wellcome thinks the WHO's priorities should be.
The final results from a large trial of a promising Ebola vaccine in Guinea, confirm that it provides a high level of protection against the disease.
There are many diseases for which we do not have a vaccine, or the vaccine we have is not effective enough. Dr Charlie Weller, who leads Wellcome’s vaccines work, highlights some of these infections, and why developing a safe and effective vaccine is particularly challenging.